Early HIV detection plays a critical role in addressing the rising HIV infection rates in the Philippines, especially among key populations and youth aged 15–24. Timely screening helps reduce public health risks, enables faster linkage to antiretroviral therapy (ART), and prevents long-term health complications.
The iCARE HIV 1&2 Rapid Screen Test offers a reliable and efficient solution for early diagnosis. With accurate antibody detection and results available in just 20 minutes, it supports healthcare professionals in closing treatment gaps and improving patient outcomes through early intervention.
Early screening empowers individuals, strengthens public health responses, and supports better HIV management across communities.
🔗 Learn more: https://www.jalmedical.com











